Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Huachen Pharmaceutical Co., Ltd. is a China-based pharmaceutical company specializing in the research, development, and production of chemical active pharmaceutical ingredients (APIs) and finished drug products. Headquartered in Hefei, Anhui Province, the company operates modern, GMP-certified manufacturing facilities dedicated to high-quality chemical synthesis. Its product portfolio primarily targets therapeutic areas such as cardiovascular diseases, metabolic disorders like diabetes, and various infectious diseases. Huachen is recognized for its production of essential generic medications, including metformin and gliclazide, which it supplies to both domestic and international markets. The company integrates R&D with large-scale manufacturing to provide cost-effective healthcare solutions. As a significant player in the regional pharmaceutical industry, it maintains a strong focus on regulatory compliance and technological innovation in API production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Huachen Pharmaceutical.